The World Health Organization (WHO) updated its global influenza surveillance summary in January 2018, noting that influenza activity in the Northern Hemisphere temperate zones continues to increase, while activity in the Southern Hemisphere temperate zone has declined to inter-seasonal baseline levels.

Between December 11 and December 24, 2017, the predominant circulating strains globally were influenza A(H3N2) and influenza B (Yamagata lineage), with a minority of nations detecting primarily A(H1N1)pdm09.

In Taiwan, the influenza epidemic has officially entered its peak seasonal transmission period. Total weekly outpatient and emergency department visits for influenza-like illness (ILI) rose steadily to 101,364 cases. The Centers for Disease Control (CDC) has activated its seasonal peak response action plan, encompassing heightened viral surveillance, expanded public antiviral medication eligibility, optimized critical care resource allocation, and strengthened risk communication. Public health authorities remind high-density institutions—including long-term care facilities, correctional facilities, military bases, and schools—to reinforce infection control protocols to prevent clustered outbreaks.

Across North America and Europe, influenza activity has risen steadily above seasonal baseline thresholds. In Canada, influenza-associated hospitalizations have exceeded historical expectations, indicating an early onset season. North Africa, Western Asia, and South Asia also reported upward trends, dominated by A(H1N1)pdm09 and influenza B.

In East Asia, influenza activity is climbing. In northern and southern provinces of mainland China and in South Korea, B-Yamagata and influenza B remain predominant, followed by A(H3N2).

According to BBC reports, the United Kingdom experienced surging influenza transmission, with week 52 influenza positivity reaching 58.3%, well above baseline. The predominant circulating strain was influenza B (47.3%), followed by A(H3N2) at 38.0%. While most circulating strains match seasonal vaccine components, some H3N2 isolates belong to newly emerged genetic subclades, prompting health authorities to closely track viral mutations.

Data from India’s Integrated Disease Surveillance Programme (IDSP) indicated that as of December 17, 2017, India had recorded over 38,000 cases and 2,232 fatalities, concentrated primarily in Gujarat (20%) and Maharashtra (16%), with Delhi recording 2,835 cases and 12 deaths.

In mainland China, Shandong Province reported entering its peak season in November—a month earlier than usual—with influenza B accounting for 87% of isolates. Beijing reported co-circulation of influenza B and influenza A (H1N1 and H3N2), with pediatric clinic visits climbing visibly. The Chinese Center for Disease Control and Prevention confirmed that seasonal winter peaks have arrived nationwide, with ILI consultation percentages exceeding the past three-year average.

In Hong Kong, influenza surveillance reported respiratory specimen positivity at 3.93% in mid-December. Public hospital bed occupancy rates surpassed 100%, prompting the Hospital Authority to add over 700 temporary inpatient beds to manage winter surge pressures.

✦ Independent Journalism · Reader Support ✦

Support Independent Perspectives & In-Depth Insights

Every thoughtful analysis and candid critique comes from our dedication to truth and quality. We choose not to follow sensational algorithms or clickbait headlines.

Sustaining independent research requires reader support. Make a one-time or monthly contribution, securely processed by Google.

Payments secured by Google · Manage or cancel anytime in your Google Account